Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

NCT00190879 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder
Comorbid Social Anxiety Disorder

Interventions

DRUG: Atomoxetine hydrochloride
DRUG: placebo

Sponsor

Eli Lilly and Company